This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Theravance, Inc.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Fei Shen - Innovator in Cognitive Disorder Treatments
Introduction
Fei Shen is an accomplished inventor based in South San Francisco, CA. He has made significant contributions to the field of cognitive disorders through his innovative research and development efforts. His work primarily focuses on the treatment of conditions such as Alzheimer's disease.
Latest Patents
Fei Shen holds a patent that provides methods for the treatment of cognitive disorders utilizing specific 5-HT receptor agonist compounds. This invention emphasizes the use of these compounds in combination with other agents, particularly acetylcholinesterase inhibitors, to enhance treatment efficacy for Alzheimer's disease and other cognitive disorders. He has 1 patent to his name.
Career Highlights
Throughout his career, Fei Shen has worked with notable companies, including Theravance, Inc. and Theravance Biopharma R&D IP, LLC. His experience in these organizations has allowed him to develop and refine his innovative approaches to treating cognitive disorders.
Collaborations
Fei Shen has collaborated with several professionals in his field, including David Beattie and Jacqueline A. M. Smith. These partnerships have contributed to the advancement of his research and the successful development of his inventions.
Conclusion
Fei Shen's work in the treatment of cognitive disorders showcases his dedication to improving patient outcomes through innovative methods. His contributions to the field are invaluable and continue to inspire future research and development efforts.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile